/////
Charge Enterprises, Inc.
(Formerly TransWorld Holdings, Inc.
And GoIP Global, Inc.)
and Subsidiaries
CONSOLIDATED FINANCIAL STATEMENTS
For the Six Months Ended
June 30, 2021
CHARGE ENTERPRISES, INC.
(FORMERLY TRANSWORLD HOLDINGS, INC. AND GOIP GLOBAL, INC.)
AND SUBSIDIARIES
FOR THE SIX MONTHS ENDED JUNE 30, 2021
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | |
Consolidated Financial Statements | |
Consolidated Balance Sheets at June 30, 2021 (Unaudited) and December 31, 2020 (As Restated) | F-1 |
Consolidated Statements of Operations (Unaudited) for the three and six months ended June 30, 2021 and 2020 | F-2 |
(As Restated) | |
Consolidated Statements of Comprehensive Loss (unaudited) for the six months ended June 30, 2021 and 2020 (As | F-3 |
Restated) |
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) for the six months ended June 30, 2021 | F-4-F-5 |
and 2020 (As Restated) | |
Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30, 2021 and 2020 (As Restated) | F-6 |
Notes to Unaudited Consolidated Financial Statements | F-7 |
-1-
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and
Stockholders of Charge Enterprises, Inc.
Results of Review of Interim Financial Information
We have reviewed the consolidated balance sheets of Charge Enterprises, Inc. and subsidiaries (the Company) as of June 30, 2021, and the related consolidated statements of operations, comprehensive income (loss), and stockholders equity and cash flows for the six-months ended June 30, 2021 and 2020, and the related notes (collectively referred to as the interim consolidated financial statements). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim consolidated financial statements for them to be in conformity with accounting principles generally accepted in the United States of America.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)(PCAOB), the balance sheet of the Company at December 31, 2020, and the related statements of operations, comprehensive income (loss), changes in stockholders' equity and cash flows for the year the ended (not presented herein); and in our report dated July 13, 2021 (except for note 5 as to which the date is August 17, 2021), we expressed an unqualified opinion on those financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of December 31, 2020, is fairly stated, in all material respects, in relation to the balance sheet from which it has been derived.
Basis for Review Results
These interim consolidated financial statements are the responsibility of the Company's management. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
s Seligson & Giannattasio, LLP
Seligson & Giannattasio, LLP White Plains, New York
October 22, 2021 (except for Note 3 as to which the date is November 9, 2021)
CHARGE ENTERPRISES, INC.
(FORMERLY TRANSWORLD HOLDINGS, INC. AND GOIP GLOBAL, INC.)
AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(As Restated) | |||||
June 30, 2021 | |||||
(Unaudited) | December 31, 2020 | ||||
ASSETS | |||||
Current assets | |||||
Cash and cash equivalents | $ | 10,046,036 | $ | 11,629,303 | |
Accounts receivable, net | 64,799,923 | 64,129,327 | |||
Inventory | 196,544 | - | |||
Deposits and prepaids | 677,755 | 370,081 | |||
Other current assets net | 359,945 | 227,307 | |||
Investment in marketable securities | 10,170,036 | 3,249,710 | |||
Investment in non-marketable securities | 248,485 | 149,262 | |||
Accrued revenue | 2,274,442 | - | |||
Total current assets | 88,773,166 | 79,754,990 | |||
Property, plant and equipment, net | 3,120,024 | 1,774,176 | |||
Capital lease asset | 216,876 | - | |||
Right-of-use asset | 586,603 | - | |||
Non-current assets | - | 259,157 | |||
Goodwill | 30,812,563 | 17,175,990 | |||
Deferred tax asset | 3,638,389 | 443,006 | |||
Total assets | $ | 127,147,621 | $ | 99,407,319 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||
Current liabilities: | |||||
Accounts payable | $ | 73,076,997 | $ | 69,914,181 | |
Accrued liabilities | 1,867,661 | 785,172 | |||
Deferred revenue | - | 3,455,886 | |||
Convertible notes payable, net of discount | 2,727,912 | 1,436,144 | |||
Convertible notes payable, related party, net of discount | - | 275,984 | |||
Line of credit | 1,081,553 | - | |||
Related party payable | - | 189,312 | |||
Derivative liabilities | - | 749,600 | |||
Capital lease liability | 168,468 | - | |||
Lease liability | 175,980 | - | |||
Total current liabilities | 79,098,571 | 76,806,279 | |||
Non-current liabilities: | |||||
Lease liability, non-current | 406,081 | - | |||
Notes payable, net of discount | 10,078,997 | - | |||
Convertible notes payable, net of discount | 3,319,598 | 1,947,945 | |||
Total liabilities | 92,903,247 | 78,754,224 | |||
Mezzanine Equity | |||||
Series B Preferred Stock, 2,395,105 authorized; 2,395,105 and 0 shares | |||||
issued and outstanding as of June 30, 2021 and December 31, 2020 | 6,850,000 | - |
Commitments and contingencies
Stockholder's Equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized;
Series A: 100,000 authorized; 1,000,000 and 0 shares issued and | |||||||
outstanding at June 30, 2021 and December 31, 2020 | 1,000 | 1,000 | |||||
Common stock, $0.001 par value; 6,800,000,000 shares authorized | |||||||
152,279,063 and 140,018,383 issued and outstanding at June 30, 2021 | |||||||
and December 31, 2020 | 152,278 | 140,018 | |||||
Common stock to be issued, 5,421,302 and 13,425,750 shares at June 30, 2021 and December | |||||||
31, 2020 | 5,422 | 13,426 | |||||
Additional paid in capital | 91,066,415 | 72,583,222 | |||||
Accumulated other comprehensive income (loss) | (21,711) | 60,375 | |||||
Accumulated deficit | (63,809,030) | (52,144,946) | |||||
Total stockholders' equity | 27,394,374 | 20,653,095 | |||||
Total liabilities and stockholders' equity | $ | 127,147,621 | $ | 99,407,319 |
The accompanying notes are an integral part of these consolidated financial statements.
F-1
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Clenergen Corp. published this content on 12 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 November 2021 15:04:14 UTC.